脑梗死是一种比较常见的脑血管疾病,特点是高致残率和高致死率。因而,对患者病情进行早期有效的判断,从而指导临床医生为患者制定恰当的治疗方案,使患者死亡率进一步降低。研究发现D-二聚体(D-Dimer, D-D)和超敏C反应蛋白(High Sensitive C-Reactive Protein, hs-CRP)在急性脑梗死中具有一定诊断价值。本文对D-二聚体、超敏C反应蛋白在急性脑梗死诊断方面的应用价值进行阐述。Cerebral infarction is a relatively common cerebrovascular disease, with characterized by high disability rate and high fatality rate. Therefore, early and effective assessment of patients’ conditions can guide clinicians to formulate appropriate treatment plans for patients, and further reduce the mortality of patients. It is found that D-Dimer (D-D) and high sensitive C-reactive protein (hs-CRP) has high clinical value in acute cerebral infarction. This article reviews the application value of D-Dimer (D-D) and high sensitive C-reactive protein (hs-CRP) in the diagnosis of acute cerebral infarction.
癫痫患者在神经科是很常见的,癫痫患者一经确诊,就会面临巨大的心理压力。患者常常失去了开车的权力,也不能饮浓茶、咖啡、可乐等,甚至不能单独洗澡。癫痫患者常常伴有抑郁情绪,抑郁情绪比抑郁症病情稍轻,主要表现为稍长时间的情绪低落、兴趣丧失、睡眠障碍、自杀意向。若未及时发现,长此以往,则会使患者病情恶化,甚至引起患者自杀。本文从癫痫共患抑郁的流行病学、发病机制、危险因素、筛查、治疗等方面综述,为临床医生提供帮助。Patients with epilepsy are quite common in the neurology department. Once diagnosed, they will face tremendous psychological pressure. They are often unable to drive, not allowed to drink strong tea, coffee, cola, etc., and may even be unable to take a bath alone. Patients with epilepsy are often accompanied by depressive emotions, which are a bit milder than depression, mainly shown as relatively long-term low mood, loss of interest, sleep disorders, and suicidal intentions. If not detected in time, as time passes, the patient’s condition will worsen and may even lead to the patient’s suicide. This article reviews the epidemiology, pathogenesis, risk factors, screening, and treatment of epilepsy comorbid with depression, so as to assist clinicians.
癫痫是最常见的慢性神经系统疾病之一,随着癫痫研究的深入,癫痫共病引起了人们的广泛关注。癫痫共病可分为精神类共病和非精神类共病,相关数据显示EP患者的共病发生率很高。加强对共病的了解不仅有助于尽早预防危险因素,而且可以考虑到癫痫治疗的长期益处,而且可以提高癫痫患者的生活质量,促进整体健康。本文就癫痫精神类共病研究进展做一综述,讨论了共病的流行性学、发病机制、筛查方法和治疗手段,以识别和治疗早期癫痫患者的伴随疾病,为更合理的协同治疗策略提供依据。Epilepsy is one of the most common chronic neurological disorders, and with the deepening of epilepsy research, epilepsy co-morbidities have attracted widespread attention. Epilepsy co-morbidities can be classified into psychiatric co-morbidities and non-psychiatric co-morbidities, and relevant data show that the incidence of co-morbidities in EP patients is high. Increased understanding of co-morbidities not only helps to prevent risk factors as early as possible, but also allows us for consideration of the long-term benefits of epilepsy treatment, and it can improve the quality of life of people with epilepsy and promote overall health. This article provides a review of the progress in the study of psychiatric co-morbidities in epilepsy, discussing the epidemiology, pathogenesis, screening methods, and treatments of co-morbidities in order to identify and treat concomitant disorders in early-stage patients with epilepsy, and to provide the basis for more rational and synergistic therapeutic strategies.
